(Q37543152)

20 August 2017

1 reference

title

Treatment for colorectal liver metastases: a review (English)

1 reference

20 August 2017

Hiroshi Shimada

1

1 reference

20 August 2017

Kuniya Tanaka

series ordinal

2

1 reference

20 August 2017

Itaru Endou

series ordinal

3

1 reference

20 August 2017

Yasushi Ichikawa

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

7 July 2009

1 reference

Langenbeck's Archives of Surgery

20 August 2017

published in

1 reference

20 August 2017

volume

394

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

973-983

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-009-0530-8

20 August 2017

exact match

0 references

cites work

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00423-009-0530-8

[Epidemiology of colorectal cancer liver metastases]

21 January 2018

1 reference

12 December 2020

Liver resection for colorectal metastases

1 reference

12 December 2020

Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases

1 reference

12 December 2020

Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

1 reference

12 December 2020

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

1 reference

12 December 2020

Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases

1 reference

12 December 2020

Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study

1 reference

12 December 2020

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

1 reference

12 December 2020

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.

1 reference

12 December 2020

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial

1 reference

12 December 2020

The impact of margins on outcome after hepatic resection for colorectal metastasis

1 reference

12 December 2020

Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma

1 reference

12 December 2020

Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis

1 reference

12 December 2020

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

1 reference

12 December 2020

Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma

1 reference

12 December 2020

Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver

1 reference

12 December 2020

Role of hepatectomy in treating multiple bilobar colorectal cancer metastases

1 reference

12 December 2020

Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases

1 reference

12 December 2020

Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis

1 reference

12 December 2020

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

1 reference

12 December 2020

Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry.

1 reference

12 December 2020

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

1 reference

12 December 2020

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

12 December 2020

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors

1 reference

12 December 2020

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

1 reference

12 December 2020

Repeat hepatectomy for colorectal liver metastases

1 reference

12 December 2020

Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm

1 reference

12 December 2020

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

1 reference

12 December 2020

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

1 reference

12 December 2020

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases

1 reference

12 December 2020

A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer

1 reference

12 December 2020

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

1 reference

12 December 2020

Extended resections of liver metastases from colorectal cancer.

1 reference

12 December 2020

Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.

1 reference

12 December 2020

Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases

1 reference

12 December 2020

Hepatectomy for colorectal metastases in the presence of extrahepatic disease

1 reference

12 December 2020

Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases

1 reference

12 December 2020

An update on hepatic arterial infusion chemotherapy for colorectal cancer

1 reference

12 December 2020

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

12 December 2020

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors

1 reference

12 December 2020

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Portal vein embolization: rationale, technique and future prospects

1 reference

12 December 2020

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Trends in long-term survival following liver resection for hepatic colorectal metastases

1 reference

12 December 2020

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

12 December 2020

Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?

1 reference

12 December 2020

Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy

1 reference

12 December 2020

Urgent need for a new staging system in advanced colorectal cancer.

1 reference

12 December 2020

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

12 December 2020

Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome

1 reference

12 December 2020

Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes

1 reference

12 December 2020

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

1 reference

12 December 2020

Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases

1 reference

12 December 2020

Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study

1 reference

12 December 2020

A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma

1 reference

12 December 2020

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

12 December 2020

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients

1 reference

12 December 2020

Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.

1 reference

12 December 2020

Major liver resections synchronous with colorectal surgery

1 reference

12 December 2020

Hepatic resection for colorectal metastases: value for risk scoring systems?

1 reference

12 December 2020

Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients

1 reference

12 December 2020

Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy

1 reference

12 December 2020

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

12 December 2020

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

1 reference

12 December 2020

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

1 reference

12 December 2020

Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

1 reference

12 December 2020

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

1 reference

12 December 2020

Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

1 reference

12 December 2020

Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases

1 reference

12 December 2020

Current value of intraoperative sonography during surgery for hepatic neoplasms

1 reference

12 December 2020

Nodular regenerative hyperplasia in partial hepatectomy specimens

1 reference

12 December 2020

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

1 reference

12 December 2020

Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases

1 reference

12 December 2020

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

12 December 2020

Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients

1 reference

12 December 2020

Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases

1 reference

12 December 2020

Radiofrequency Ablation of Malignant Liver Tumors

1 reference

12 December 2020

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

12 December 2020

Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.

1 reference

12 December 2020

Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer.

1 reference

12 December 2020

Incidence of gastrointestinal cancers in France

1 reference

12 December 2020

Prospective Evaluation of Two-Stage Hepatectomy Combined with Selective Portal Vein Embolisation and Systemic Chemotherapy for Patients with Unresectable Bilobar Colorectal Liver Metastases

1 reference

12 December 2020

Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer

1 reference

12 December 2020

Simultaneous resection of colorectal primary tumour and synchronous liver metastases

1 reference

12 December 2020

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

12 December 2020

Repeat hepatic resection using a radiofrequency-assisted technique

1 reference

12 December 2020

Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive

1 reference

12 December 2020

Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial

1 reference

12 December 2020

Radiofrequency ablation of unresectable hepatic malignancies: lessons learned

1 reference

12 December 2020

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

1 reference

12 December 2020

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

12 December 2020

Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases

1 reference

12 December 2020

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

12 December 2020

Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer

1 reference

12 December 2020

Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience

1 reference

12 December 2020

Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results

1 reference

12 December 2020

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases

1 reference

12 December 2020

Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?

1 reference

12 December 2020

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

12 December 2020

Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver

1 reference

12 December 2020

Resection of colorectal liver metastases

1 reference

12 December 2020

Is extended hepatectomy for hepatobiliary malignancy justified?

1 reference

12 December 2020

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

1 reference

12 December 2020

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal

1 reference

12 December 2020

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

12 December 2020

Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy

1 reference

12 December 2020

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

1 reference

12 December 2020

Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents

1 reference

12 December 2020

Opportunities for cancer epidemiology in developing countries

1 reference

12 December 2020

Effect of type of resection on outcome of hepatic resection for colorectal metastases

1 reference

12 December 2020

Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology t

1 reference

12 December 2020

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

1 reference

12 December 2020

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

1 reference

12 December 2020

Indicators of prognosis after hepatic resection for colorectal secondaries

1 reference

12 December 2020

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

12 December 2020

10.1007/S00423-009-0530-8

Identifiers

DOI

1 reference

20 August 2017

1 reference